5 SEP 2018

DotBio announces new advisors

Dr. Bertil Lindmark and Dr. Dineli Wickramasinghe join DotBio as scientific advisors.


6 AUG 2018

 

DOTBIO COMPLETES US$2.3M SEED ROUND

DotBio successfully launches to focus on next generation of immuno-oncology drugs based on domain antibodies.


12-14 Mar 2018

 

 

 

DotBio will be present at the BIOEUROPE SPRING 2018 in Amsterdam

DotBio will be present at BIOEUROPE SPRING 2018 in Amsterdam to search for partners to accelerate its lead and preclinical development projects.


7 Aug 2017

DotBio will be presenting at the 2017 BIO Investor Forum

DotBio will be presenting the company at the 2017 BIO Investor Forum, happening October 17-18, 2017 in San Francisco.


6 Jun 2017

DotBio is incorporated in Singapore

DotBio was incorporated today in Singapore as a Private Limited company. The company has officially started operations and is actively looking for investors for its seed funding round.


NATURE COMMUNICATIONS 2013

Asial I, Cheng YX, Engman H, Dollhopf M, Wu B, Nordlund P, Cornvik T.

Engineering protein thermostability using a generic activity-independent biophysical screen inside the cell. Nature Communications. 2013; 4: 2901.